Drug Trial Radar · NCT01287351
Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
Last checked: Nov 19, 2026Latest source record: Aug 5, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
82,903
Actual
Start
Jan 2004
Primary completion
Dec 2008
Study completion Oct 2010
Sponsor
- Lead sponsor
- Research in Real-Life LtdResearch network
- Sponsor type
- Research network
- Collaborators
- i3 Research; Teva Branded Pharmaceutical Products R&D, Inc.
- First posted
- Feb 1, 2011
Design
- Study type
- Observational
- Who can join
- All sexes, from 5 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will compare the absolute and relative effectiveness and cost-effectiveness of asthma management in patients in the USA on inhaled corticosteroid (ICS) maintenance therapy as HFA-BDP (Qvar®) pressurised metered dose inhaler (pMDI) compared with fluticasone propionate (FP) pMDI. .
Conditions
- Asthma
Interventions
extra-fine hydrofluoroalkane beclometasone dipropionateDrug
Fluticasone propionateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proxy Asthma ControlTime frame: One-year outcome period
- Total number of asthma exacerbations and exacerbation rate ratioTime frame: One-year outcome period
- Revised proxy asthma controlTime frame: One-year outcome period
- Risk Domain Asthma Control (in the subgroup of patients aged 12-60, the following additional analysis was done)Time frame: One year outcome period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research in Real Life
Cawston, Norfolk, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.